ZSCAN4 and facioscapulohumeral muscular dystrophy: Further evaluation of EEV2-PMO-PAS in FSHD patient-derived muscle cells showed a significant reduction in ZSCAN4 transcript expression to near-healthy levels (Figure 6B).